← FDA Drug Approvals (Drugs@FDA)
NORGESTREL AND ETHINYL ESTRADIOL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2017-05-08
Drug application
- FDA Application #
ANDA202875- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NORGESTREL AND ETHINYL ESTRADIOL
- Generic name
- Ethinyl Estradiol
- Active ingredients
- ETHINYL ESTRADIOL; NORGESTREL
- Dosage form
- TABLET
- Route
- ORAL-28
- Marketing status
- Discontinued
- Sponsor
- MYLAN LABS LTD
- First approval
- 2017-05-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown